Company
Bone Therapeutics SA
Headquarters: Gosselies, Belgium
Employees: 30
CEO: Dr. Miguel Forte M.D., Ph.D.
Market Cap
€1.1 Million
EUR as of Jan. 1, 2024
US$1.2 Million
Bone Therapeutics SA Categories
Belgium Healthcare BiotechnologyBelgium Healthcare Belgium Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa studies for the treatment of delayed-union fractures and lumbar spinal fusion. The company is also developing JTA-004, an intra-articular injectable, which is in phase III development for the treatment of osteoarthritic pain in the knee. Bone Therapeutics SA has collaborations with Cerhum, 3D-Side, mSKIL, and IREC to develop personalized, tissue engineered bone implants; and a research partnership with Implant Therapeutics to access induced pluripotent stem cells. The company was incorporated in 2006 and is based in Gosselies, Belgium.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
Bone Therapeutics SA has the following listings and related stock indices.
Stock: Euronext: BOTHE wb_incandescent
Stock: FSX: BT1 wb_incandescent